MMP9 and Myocardial fibrosis: In AMI rat models, Sal-B selectively inhibits MMP-9 activity, effectively augments left ventricular wall thickness, enhances cardiac contractility, and attenuates myocardial fibrosis (Ma et al., 2015; Sun et al., 2021; Luo et al., 2023).